Falsified meds do not yet impose a serious threat in Hungary and the EU

3 April 2018
hungary_flag-1-

“Due to strict regulations and legislatory monitoring no falsified or unauthorized medication has entered the legal drug supply chain in Hungary until now, stated the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM).

This does not mean, however, that obtaining locally unauthorized preparations would be impossible, but illegal trade is mainly restricted to the internet. As of next February a pharmaceutical manufacturer specific European Union directive will come into effect: every packaging unit of prescription medication will have to be equipped with an individual identification number, the AIPM noted.

This predicts a highly complicated IT system, and to operate such, every EU member state was obligated to establish a national organization, which is called HUMVO (Hungarian Medicines Verification Organization Non-profit Ltd) in Hungary. The new system will control 17 billion units of medication in the EU on a yearly basis, which come from 4600 different manufacturing facilities and will be released at 177,000 different end points.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical